نتایج جستجو برای: tyrosinemia type ii
تعداد نتایج: 1796109 فیلتر نتایج به سال:
In this article, we use a measure of expected true evidence for determine the required sample size in type-II censored experiments for obtaining statistical evidence in favor of one hypothesis about the exponential mean against another.
Tyrosinemia type I: long-term outcome in a patient treated with doses of NTBC lower than recommended
Oculocutaneous albinism (OCA) is a group of genetic disorders characterized by hypopigmentation of the skin, hair, and eyes. Affected individuals experience reduced visual acuity and substantially increased skin cancer risk. There are four major types of OCA (OCA1-OCA4) that result from disruption in production of melanin from tyrosine. Current treatment options for individuals with OCA are lim...
Hereditary tyrosinemia type 1 (HT1) is a severe human autosomal recessive disorder caused by the deficiency of fumarylacetoacetate hydroxylase (FAH), an enzyme catalyzing the last step in the tyrosine degradation pathway. Lack of FAH causes accumulation of toxic metabolites (fumarylacetoacetate and succinylacetone) in blood and tissues, ultimately resulting in severe liver and kidney damage wit...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید